Liki24, a Ukrainian platform for booking and delivery of medicines, started operating in Bucharest, the capital of Romania, at the end of June 2021. The next step is to enter the Hungarian market. Anton Avrinsky, CEO of the company, shared this information in an interview with Forbes Ukraine.
According to the CEO of Liki24.com, the choice of new markets for scaling was made in three stages, and one of the investors of the startup, Genesis Investments, was also involved in the analysis process.
As a result, the company chose Romania, a country with a small pharmaceutical market and low competition. If everything works out, the company plans to launch the service in two or three countries, one of which may be outside of Europe, Avrinsky said.
About Liki24
Liki24 was launched in Ukraine in 2017. According to Forbes, over 600,000 Ukrainians have already used its medication delivery services. During its existence, the startup managed to raise $6 million in investments, including funding from Genesis Investments, TA Ventures, and Horizon Capital. The company’s turnover grew to $20 million in 2020.
In July 2020, on its 3rd birthday, Liki24 was launched in Poland. The service is now available in Warsaw, Krakow, and Gdansk.
In May, the startup, in cooperation with Terralab, launched Lab24, a test-taking service. It offers any tests, including PCR and COVID-19 antibody tests, at home or an office.
